These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37101738)

  • 1. Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial.
    Jessen S; Lemminger A; Backer V; Fischer M; Di Credico A; Breenfeldt Andersen A; Bangsbo J; Hostrup M
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37101738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled beta
    Jeppesen JS; Jessen S; Thomassen M; Backer V; Bangsbo J; Hostrup M
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14500. PubMed ID: 37880916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C.
    Tjørhom A; Riiser A; Carlsen KH
    Scand J Med Sci Sports; 2007 Dec; 17(6):628-35. PubMed ID: 17316372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of formoterol inhalation on endurance performance in hypobaric conditions.
    Riiser A; Tjørhom A; Carlsen KH
    Med Sci Sports Exerc; 2006 Dec; 38(12):2132-7. PubMed ID: 17146320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled salbutamol induces leanness in well-trained healthy females but not males during a period of endurance training: a randomised controlled trial.
    Hostrup M; Weinreich C; Bjerre M; Kohlbrenner D; Bangsbo J; Jessen S
    ERJ Open Res; 2023 Nov; 9(6):. PubMed ID: 38152086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
    Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
    JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
    van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
    Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic β
    Hostrup M; Onslev J; Jacobson GA; Wilson R; Bangsbo J
    J Physiol; 2018 Jan; 596(2):231-252. PubMed ID: 28983994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
    Janjua S; Schmidt S; Ferrer M; Cates CJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
    Aziz I; Lipworth BJ
    Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.